15/10/02说明:此前论坛服务器频繁出错,现已更换服务器。今后论坛继续数据库备份,不备份上传附件。

肝胆相照论坛

 

 

肝胆相照论坛 论坛 肝硬化论坛 治疗肝硬化的多学科团队方法
查看: 524|回复: 3
go

治疗肝硬化的多学科团队方法 [复制链接]

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

1
发表于 2021-10-22 11:33 |只看该作者 |倒序浏览 |打印
治疗肝硬化的多学科团队方法
      

    全文
    指标
    获得许可
    引用这篇文章

作者: Zhang YR, Wang H, Zhou N, Zhang YD, Lin Y, Wu LY, Wei SF, Ma YY, Wang CX

2021 年 7 月 7 日收到

2021 年 8 月 19 日接受出版

2021 年 10 月 22 日出版 2021 年卷:14 页 5443—5450

DOI https://doi.org/10.2147/JIR.S328334

检查抄袭 是

单一匿名同行评审

同行评审意见 2

审稿编辑:全宁教授
下载文章 [PDF]

张悦荣,1 王慧,2 周宁,2 张耀迪,1,2 林燕,1,2 吴丽阳,1,2 魏世芳,2 马燕云,2,3王春霞3

1重庆医科大学附属城中医院消化内科,重庆; 2兰州市第一人民医院感染科,甘肃 730050; 3 兰州市第一人民医院检验科, 甘肃 730050

通讯员:张月荣
重庆市沙坪坝区大学城中路55号,重庆医科大学城医院消化内科,401331
电话/传真 +86 102365714142
邮箱 [email protected]

目的:探讨多学科团队方法(MDT)治疗肝硬化的可行性,并确定影响其实施的关键因素。
方法:回顾性研究307例失代偿期肝硬化患者的资料。接受两种以上治疗措施的患者被分配到MDT组(n=228),仅接受对症药物治疗的患者被分配到传统治疗组(n=79)。随访时间4~10年,平均随访5.7年。分析了乙型肝炎病毒脱氧核糖核酸、丙型肝炎病毒核糖核酸和肝病自身抗体的生化检测结果。
结果:两组性别及肝功能Child-Pugh分级差异无统计学意义。 MDT组在职业构成、病因构成、5年生存率、年住院次数等方面均优于传统治疗组。 MDT组主要死因依次为肝癌、感染、肠系膜血栓形成、非肝病,药物治疗组为肝功能衰竭、消化道出血、感染、肝癌.两组之间存在显着的统计学差异(p < 0.05)。在多学科治疗中,病因治疗是应用最广泛的治疗方法,占79.8%,其次是内镜治疗(33.3%)、腹腔引流腹水回输(25%)、脾切除联合断流术(11.4%)和干细胞移植和肝移植(1.8%)。
结论:MDT可改善肝硬化患者的疗效和预后,提高患者依从性。多学科干预后,长期生存的肝硬化患者死亡率谱发生变化,肝癌和非肝病死亡率增加。

关键词:肝硬化,失代偿期,多学科团队模式,传统治疗,回顾性研究

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

2
发表于 2021-10-22 11:33 |只看该作者
A Multidisciplinary Team Approach to the Treatment of Liver Cirrhosis
      

    Fulltext
    Metrics
    Get Permission
    Cite this article

Authors Zhang YR, Wang H, Zhou N, Zhang YD, Lin Y, Wu LY, Wei SF, Ma YY, Wang CX

Received 7 July 2021

Accepted for publication 19 August 2021

Published 22 October 2021 Volume 2021:14 Pages 5443—5450

DOI https://doi.org/10.2147/JIR.S328334

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Ning Quan
Download Article [PDF]

Yue-Rong Zhang,1 Hui Wang,2 Ning Zhou,2 Yao-Di Zhang,1,2 Yan Lin,1,2 Li-Yang Wu,1,2 Shi-Fang Wei,2 Yan-Yun Ma,2,3 Chun-Xia Wang3

1Department of Gastroenterology, University-Town Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Infectious Diseases, The First People’s Hospital of Lanzhou, Gansu, 730050, People’s Republic of China; 3Department of Laboratory, The First People’s Hospital of Lanzhou, Gansu, 730050, People’s Republic of China

Correspondence: Yue-Rong Zhang
Department of Gastroenterology, University-Town Hospital of Chongqing Medical University, No. 55 University Town Middle Road, Shapingba District, Chongqing, 401331, People’s Republic of China
Tel/Fax +86 102365714142
Email [email protected]

Objective: To explore the feasibility of treating cirrhosis using a multidisciplinary team approach (MDT) and to pinpoint the key factors influencing its implementation.
Methods: The data of 307 patients with decompensated cirrhosis were studied retrospectively. Patients who received more than two treatment measures were assigned to the MDT group (n=228), and patients who received symptomatic medical drug treatment only were assigned to the traditional treatment group (n=79). The follow-up period ranged from 4 to 10 years, and the average follow-up period was 5.7 years. The results of the biochemical tests for hepatitis B virus deoxyribonucleic acid, hepatitis C virus ribonucleic acid, and autoantibodies to liver disease were analyzed.
Results: The differences in gender and Child–Pugh grade of liver function between the two groups were not statistically significant. The MDT group had obvious advantages over the traditional treatment group in occupational composition, etiology composition, 5-year survival rate and annual hospitalization times. The leading causes of death in the MDT group, in descending order, were liver cancer, infection, mesenteric thrombosis, and non-hepatic disease, and, in the medical treatment group, they were liver failure, gastrointestinal bleeding, infection, and liver cancer. There was a significant statistical difference between the two groups (p < 0.05). In the multidisciplinary treatment, etiological treatment was the most widely used treatment, accounting for 79.8%, followed by endoscopic treatment (33.3%), peritoneal drainage and ascites reinfusion (25%), splenectomy combined with devascularization (11.4%) and stem cell transplantation and liver transplantation (1.8%).
Conclusion: An MDT can improve the efficacy and prognosis of patients with cirrhosis and improve patient compliance. After multi-disciplinary intervention, the mortality spectrum of long-term survival patients with cirrhosis changes, and the mortality rate of liver cancer and non-liver disease increases.

Keywords: liver cirrhosis, decompensated period, multidisciplinary team mode, traditional treatment, retrospective study

Rank: 8Rank: 8

现金
62111 元 
精华
26 
帖子
30437 
注册时间
2009-10-5 
最后登录
2022-12-28 

才高八斗

3
发表于 2021-10-22 11:34 |只看该作者

Rank: 2

现金
16 元 
精华
帖子
11 
注册时间
2021-10-10 
最后登录
2021-11-8 
4
发表于 2021-10-25 11:24 |只看该作者
好!
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册

肝胆相照论坛

GMT+8, 2024-11-16 05:25 , Processed in 0.013795 second(s), 11 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.